Abstract:A combined enhanced inactivated polio vaccine (EIPV) and oral polio vaccine (OPV) programme was introduced in Israel in 1990, with the purpose of providing a solution to the persistent polio morbidity in spite of a 30 year long OPV programme. The schedule comprised two doses of EIPV administered at the age of 2 and 4 months, intercalated with two doses of OPV at 4 and 6 months, followed by a reinforcing dose with the two vaccines simultaneously administered at 12 months. The 5-year evaluation of the programme included: the assessment of clinical suspicions of polio, early immune response in successive cohorts administered the new schedule, dynamics of the immune profile in a cohort followed up to the age of 5, and monitoring of wild poliovirus excretion in sewage specimens collected in 25 permanent sites throughout Israel as well as from the Palestinian Authority. No paralytic polio cases associated with a wild or vaccinal poliovirus strain were detected since the introduction of the programme. At the age of 4 months, one week after administration of the second EIPV and first OPV dose, 100% seropositivity and high geometric mean titres (GMTs) of neutralizing antibody (NA) to the three vaccinal and to the wild poliovirus type 1, responsible for the 1988 polio outbreak, were observed. No change in percent of seropositivity occurred between the age of 6 and 12 months. Thirty days after the IPV and OPV reinforcing doses, GMTs to each of the four poliovirus strains were > or = 3037. Up to the age of 5, the seropositivity was unchanged. After a 2.5-10-fold decline in the first year following the completion of the programme, GMTs to the three vaccinal and the wild poliovirus strain levelled off at rather high values, considered protective. Between 1990 and 1995, 16 wild poliovirus type 1 strains were isolated in three separate episodes in Gaza Strip sewage and once only in one Israeli site very close to Gaza City. The rapidly established, high and persistent NA titre to the vaccinal and wild poliovirus strains and the presence of immunological memory are indicative of high individual protection throughout the first 5 years of life. The only one-time introduction, without circulation, of a wild poliovirus strain in a single Israeli settlement suggests community protection. The intercalated programme offers a contribution to polio eradication by providing a solution to the primary and secondary failure associated with OPV, as well as to the control of vaccine-associated paralytic poliomyelitis.

Study on strategies and effects of eradicating poliomyelitis in Huaian

Analysis of pathogens and clinical characterization of hand, foot and mouth disease in Huzhou city from 2013 to 2014

The Investigation and Analysis of Varicella Vaccine Immunization Effect in Yuecheng District

Analysis on Working Status to Retain the Situation of No-polio in Jiangxi Province,2003

Thirty Years of Experience of Acute Flaccid Paralysis Surveillance for Polio - China, 1993-2022

Combating a resurgence of poliomyelitis through public health surveillance and vaccination

Effect evaluation on immunity and surveillance of diphtheria elimination in Rizhao City.

Vaccine-derived Poliovirus Surveillance in China During 2001–2013: the Potential Challenge for Maintaining Polio Free Status

The Effect of Hepatitis B Vaccination after Five Years on an Entire Population in an Insular Region of Southeast China

Israel in the elimination phase of poliomyelitis--achievements and remaining problems

Polio Epidemiology: Strategies and Challenges for Polio Eradication Post the COVID-19 Pandemic

Eradication of poliomyelitis in the United States

Post hoc analysis of two clinical trials to compare the immunogenicity and safety of different polio immunization schedules in Chinese infants

Analysis on the Surveillance of Measles in 2005 in Huai'an City and Discussion on Measles Control Strategies

[Possible method of eradication of poliomyelitis as an infection]

Exploring the path to polio eradication: insights from consecutive seroprevalence surveys among Pakistani children

Eradication of poliomyelitis in countries affected by conflict

Progresses Toward Polio Eradication in Asian Countries: Its History and Japan's Contributions

Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis

Monitoring impact of oral poliovirus vaccine on poliomyelitis trends from physiotherapy records, Ilorin, Nigeria, 1981-1988

Huaihua City,2005-2011 Legal Infectious Disease Epidemic Trend Analysis